Last reviewed · How we verify
NCT05287880
Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of MLN of ESCC
trial testing Dynamic PET/CT in Esophageal Squamous Cell Carcinoma in 60 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 10 March 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
Drugs / interventions tested
- Dynamic PET/CT
- Dynamic PET/CT
Conditions studied
- Esophageal Squamous Cell Carcinoma — all drugs for Esophageal Squamous Cell Carcinoma →
- Benign Lymph Node Neoplasm — all drugs for Benign Lymph Node Neoplasm →
- Malignant Lymph Node Neoplasm — all drugs for Malignant Lymph Node Neoplasm →
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Who can join
Adults 18 to 85, any sex, with Esophageal Squamous Cell Carcinoma or Benign Lymph Node Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients diagnosed with esophageal squamous cell carcinoma based on clinicopathology, laboratory examination and imaging criteria were selected as the research subjects, and compared with conventional 18F-FDG PET/CT. To evaluate the research value of quantitative analysis of 18F-FAPI PET/CT dynamic imaging in the classification of benign and malignant features of primary esophageal squamous cell carcinoma (ESCC) and lymphatic nodules, lesion localization, outcome and prognosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
Zhang Z, Tao J, Qiu J, Cao Z, et al · · 2024 · cited 21× · PMID 37726505 · DOI 10.1007/s13402-023-00872-z
Verify or expand the search:
- PubMed search for NCT05287880
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Esophageal Squamous Cell Carcinoma
Currently open trials in the same condition.
- NCT07503808 — A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types · Phase 1 · recruiting
- NCT07385001 — A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as N · Phase 1, PHASE2 · recruiting
- NCT07217171 — A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial · Phase 1 · recruiting
- NCT07109726 — A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · Phase 1, PHASE2 · recruiting
- NCT07090499 — A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · Phase 1 · recruiting
Other Fifth Affiliated Hospital, Sun Yat-Sen University trials
Trials by the same sponsor.
- NCT06079931 — The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia · Phase 2 · unknown
- NCT06525025 — Building a Traditional Chinese Medicine Clinical Diagnosis and Treatment Database · not yet recruiting
- NCT06060782 — Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine · Phase 1 · recruiting
- NCT06220552 — The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma · Phase 2 · recruiting
- NCT06147947 — Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05287880 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fifth Affiliated Hospital, Sun Yat-Sen University
- Last refreshed: 18 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05287880.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing